To determine the relationship between IKKα and the pathologic response to neoadjuvant chemotherapy, all 43 breast cancer samples were stratified into 3 groups based on the Miller-Payne classification system: Grade-1/2, Grade-3, and Grade-4. Here, CHUK is linked to breast carcinoma.